Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report

Documenti analoghi

• Combination of reduced post‐transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft‐versus‐host disease in human leukocyte antigen‐haploidentical peripheral blood stem‐cell transplantation
  di: Toshiki Terao, et al.
  Pubblicazione: (2024)
• B‐cell maturation antigen expression and clinical features of plasmablastic lymphoma
  di: Ning Dong, et al.
  Pubblicazione: (2024)
• Hepatic T cell lymphoma after chimeric antigen receptor T cell therapy for myeloma
  di: Joshua Mehr, et al.
  Pubblicazione: (2024)
• Increased serum B‐cell maturation antigen levels evaluated with an Elecsys‐based serum B‐cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma
  di: Evangelos Terpos, et al.
  Pubblicazione: (2024)
• Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
  di: Syed Naqvi, et al.
  Pubblicazione: (2024)